Posted in | News

New Guide on G8 Non-Residential Construction Industry

The G8 Non-Residential Construction industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to 2018). The guide also contains descriptions of the leading companies including key financial metrics and analysis of competitive pressures within the market.

Features and benefits

  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 non-residential construction market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 non-residential construction market
  • Leading company profiles reveal details of key non-residential construction market players' G8 operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the G8 non-residential construction market with forecasts
  • Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Highlights

The G8 countries contributed $649.3 billion in 2013 to the global non-residential construction industry, with a compound annual growth rate (CAGR) of -3% between 2009 and 2013. The G8 countries are expected to reach a value of $749.0 billion in 2018, with a CAGR of 2.9% over the 2013-18 period.

Among the G8 nations, the US is the leading country in the non-residential construction industry, with market revenues of $298.7 billion in 2013. This was followed by Japan and Germany, with a value of $104.9 and $63.8 billion, respectively.

The US is expected to lead the non-residential construction industry in the G8 nations with a value of $363.2 billion in 2016, followed by Japan and Germany with expected values of $111.6 and $69.8 billion, respectively.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.